University of Texas/MD Anderson Cancer Center SC - 5

Houston, Texas 77030

We've found

1 trials

at this facility

Study to Allow Access to Nilotinib for Patients Who Are on Nilotinib Treatment in a Novartis-sponsored Study

Status: Enrolling, Phase IV
Updated: 12/31/1969

from

Houston, TX

Use our guide to learn which trials are right for you!